Prosecution Insights
Last updated: April 19, 2026
Application No. 17/939,404

DIALYSIS SYSTEM WITH ONLINE DIALYSIS FLUID GENERATION

Non-Final OA §112
Filed
Sep 07, 2022
Examiner
BASS, DIRK R
Art Unit
1779
Tech Center
1700 — Chemical & Materials Engineering
Assignee
BAXTER HEALTHCARE SA
OA Round
5 (Non-Final)
62%
Grant Probability
Moderate
5-6
OA Rounds
3y 9m
To Grant
84%
With Interview

Examiner Intelligence

Grants 62% of resolved cases
62%
Career Allow Rate
515 granted / 831 resolved
-3.0% vs TC avg
Strong +22% interview lift
Without
With
+22.4%
Interview Lift
resolved cases with interview
Typical timeline
3y 9m
Avg Prosecution
32 currently pending
Career history
863
Total Applications
across all art units

Statute-Specific Performance

§101
0.3%
-39.7% vs TC avg
§103
48.6%
+8.6% vs TC avg
§102
29.0%
-11.0% vs TC avg
§112
15.9%
-24.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 831 resolved cases

Office Action

§112
DETAILED ACTION Applicant’s request for continued examination filed December 8, 2025 is acknowledged. Claims 1 and 18 are amended. Claims 1-20 are pending and further considered on the merits. Response to Amendment In light of applicant’s amendment, the examiner modifies the grounds of rejection set forth in the office action filed September 8, 2025. Claim Rejections - 35 USC § 112 The following is a quotation of the first paragraph of 35 U.S.C. 112(a): (a) IN GENERAL.—The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor or joint inventor of carrying out the invention. Claims 1-20 are rejected under 35 U.S.C. 112(a) or 35 U.S.C. 112 (pre-AIA ), first paragraph, as failing to comply with the written description requirement. The claim(s) contains subject matter which was not described in the specification in such a way as to reasonably convey to one skilled in the relevant art that the inventor or a joint inventor, or for applications subject to pre-AIA 35 U.S.C. 112, the inventor(s), at the time the application was filed, had possession of the claimed invention. Claim 1 recites a dialysis system comprising a dialysis machine having a controller, and a dialysis fluid source having a controller, where the controller of the dialysis fluid source is configured to receive a sensed fluid pressure from a pressure transducer and control a flow rate such that the flow rate of dialysis fluid matches the draw rate of a pump of the dialysis machine. However, applicant’s originally filed disclosure does not support a dialysis fluid source controller configured as recited in claim 1. For reference, applicant’s stated support appears below. [0044] In another embodiment, a system uses a fluid connection to convey information from the dialysis machine 30 to the fluid source 10. When the dialysis machine 30 draws fluid at the high rate, the fluid source 10 experiences a reduced pressure on an outlet line. A pressure transducer may be used to detect this pressure drop and increase the fluid generation rate accordingly. When the dialysis machine 30 reduces the draw rate, the pressure on the outlet line of the fluid source 10 will increase, which can be detected with the same pressure sensor, leading to a reduction in flow rate. This embodiment provides another means of conveying flow rate information. As seen above, a pressure transducer on the outlet line detects a change in pressure indicating either an increase or decrease in demand by the dialysis machine whereby a fluid generation rate (of the dialysis fluid source) is modified. In the subsequent paragraph of applicant’s disclosure, a “data connection allows the flow rate of the fluid from the source 10 to be synchronized with the draw rate of the dialysis device 30”. The data connection is defined by applicant in paragraph 0043 as a “connection between the dialysis machine 30 and the fluid source…provided by any type of data communication link, including wired, radio, infrared, Bluetooth, and the like”. Lastly, paragraph 0042 recites “the data connection provides a signal from the dialysis machine 30 to the fluid source 10 to adjust the flow setting of fluid from the fluid source 10”. Taking the relevant passages recited above as a whole, it is clear the dialysis machine controller provides the signal to synchronize the flow rate of the dialysis fluid source with the draw rate of the dialysis machine. Therefore, applicant’s recitation of a dialysis fluid source controller and said controller being configured as recited in claim 1 are considered to be new matter not present in the originally filed disclosure. Claim 18 recites the same dialysis fluid source controller configuration and is similarly rejected as presenting new matter not present in the originally filed disclosure. Response to Arguments Applicant’s arguments, filed December 8, 2025 are moot in view of the new grounds of rejection. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to DIRK R BASS whose telephone number is (571) 270-7370. The examiner can normally be reached 8-4:30 EST Monday-Friday. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Bobby Ramdhanie can be reached on (571) 270-3240. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. DIRK R. BASS Primary Examiner Art Unit 1779 /DIRK R BASS/Primary Examiner, Art Unit 1779
Read full office action

Prosecution Timeline

Sep 07, 2022
Application Filed
Apr 10, 2024
Non-Final Rejection — §112
Jun 26, 2024
Examiner Interview Summary
Jun 26, 2024
Applicant Interview (Telephonic)
Jul 16, 2024
Response Filed
Oct 28, 2024
Final Rejection — §112
Jan 15, 2025
Request for Continued Examination
Jan 18, 2025
Response after Non-Final Action
Mar 31, 2025
Non-Final Rejection — §112
Jun 30, 2025
Response Filed
Sep 04, 2025
Final Rejection — §112
Dec 08, 2025
Request for Continued Examination
Dec 12, 2025
Response after Non-Final Action
Jan 13, 2026
Non-Final Rejection — §112
Mar 03, 2026
Examiner Interview Summary
Mar 03, 2026
Applicant Interview (Telephonic)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12599667
METHODS OF PREVENTING PLATELET ALLOIMMUNIZATION AND ALLOIMMUNE PLATELET REFRACTORINESS AND INDUCTION OF TOLERANCE IN TRANSFUSED RECIPIENTS
2y 5m to grant Granted Apr 14, 2026
Patent 12594528
SPACER FILM WITH INTEGRATED LAMINATION STRIP
2y 5m to grant Granted Apr 07, 2026
Patent 12590955
METHODS AND SYSTEMS FOR PROCESSING PARTICLES
2y 5m to grant Granted Mar 31, 2026
Patent 12588779
DRIP COFFEE FILTER STRUCTURE
2y 5m to grant Granted Mar 31, 2026
Patent 12582496
Manifold For A Medical/Surgical Waste Collection Assembly
2y 5m to grant Granted Mar 24, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

5-6
Expected OA Rounds
62%
Grant Probability
84%
With Interview (+22.4%)
3y 9m
Median Time to Grant
High
PTA Risk
Based on 831 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month